Real world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin.

CONCLUSIONS: For AIP patients treated with hemin, patients treated for acute attacks may use a greater number of resources compared to patients treated prophylactically.
PMID: 31999204 [PubMed - as supplied by publisher]

Source: Journal of Medical Economics - February 1, 2020 Category: Health Management Tags: J Med Econ Source Type: research